呼吸系统疾病检测市场规模、份额、成长分析（按检测类型、按应用、按地区）- 按行业预测，2024-2031 年

2022年全球呼吸系统疾病检测市场规模为61.7亿美元，从2023年的63.4亿美元增长到2031年的78.4亿美元，预计在预测期内（2024-2031年）将以复合年增长率增长。 %。

由于气喘、慢性阻塞性肺病和肺癌等呼吸道疾病的盛行率不断上升，而污染、吸烟和人口老化又加剧了这种疾病，全球呼吸道疾病检测市场正在强劲成长。借助分子诊断、免疫检测和诊断成像技术进步，检测效率和检测结果得到提高，增加了准确诊断方法的紧迫性。 COVID-19 大流行进一步凸显了呼吸系统检测的重要性，并推动了对包括 PCR 和抗原检测在内的各种检测方法的需求。然而，挑战依然存在，包括检测成本高昂限制了低收入地区的检测、缺乏意识以及基础设施不足，特别是在发展中地区。此外，监管障碍可能会阻碍创新和产品发布，突显需要采取教育倡议来加深对测试在患者照护中关键作用的理解。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究

呼吸系统疾病检测市场规模：依检测类型

• 市场概况
• 机械测试
  • 肺活量测定法
  • 峰值流量测试
  • 肺功能检查
  • 血气测试
  • 其他的
• 影像检查
  • X射线
  • 电脑断层扫描
  • 超音波检查
  • MRI
• 体外诊断测试
  • 照护现场测试
  • 分子诊断测试

呼吸系统疾病检测市场规模：依应用分类

• 市场概况
• 慢性阻塞性肺病
• 肺癌
• 气喘
• 结核
• 其他的

按最终用途分類的呼吸系统疾病检测市场规模

• 市场概况
• 医院
• 医生诊所
• 临床实验室

呼吸系统疾病检测市场规模：按地区划分

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Beckton Dickinson and Company
• Koninklijke Philips NV
• ResMed Inc.
• Medtronic
• MG Diagnostic Corporation
• Abbott
• ThermoFisher Scientific
• Biomerieux
• QIAGEN
• Seimens Healthineers AG
• F. Hoffmann-La Roche Ltd
• SDI Diagnostics
• BD
• Niterra Co., Ltd.
• QuantuMDx Group Ltd.
• COSMED srl
• Bird Healthcare
• visby medical
• Seegene Inc
• Bio-Rad Laboratories Inc

结论和建议

Global Respiratory Disease Testing Market size was valued at USD 6.17 billion in 2022 and is poised to grow from USD 6.34 billion in 2023 to USD 7.84 billion by 2031, growing at a CAGR of 2.7% during the forecast period (2024-2031).

The global respiratory disease testing market has witnessed robust growth, fueled by the rising prevalence of respiratory conditions like asthma, COPD, and lung cancer, exacerbated by pollution, smoking, and aging populations. The urgency for accurate diagnostic methods has escalated, supported by technological advancements in molecular diagnostics, immunoassays, and imaging, which enhance testing efficiency and outcomes. The COVID-19 pandemic further underscored the importance of respiratory testing, driving demand for diverse testing methods, including PCR and antigen tests. However, challenges remain, including high testing costs limiting access in low-income areas, awareness deficits, and inadequate infrastructure, particularly in developing regions. Additionally, regulatory hurdles may impede innovation and product launches, emphasizing the need for educational initiatives to enhance understanding of testing's critical role in patient care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Respiratory Disease Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Respiratory Disease Testing Market Segmental Analysis

Global Respiratory Disease Testing Market is segmented by test type, application, end-use and region. Based on test type, the market is segmented into mechanical tests, imaging tests and in-vitro diagnostic tests. Based on application, the market is segmented into chronic obstructive pulmonary disease, lung cancer, asthma, tuberculosis and other. Based on end-use, the market is segmented into hospital, physicians clinic and clinical laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Respiratory Disease Testing Market

The global respiratory disease testing market is primarily driven by the escalating incidence of respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and lung cancer. Contributing factors such as environmental pollution, tobacco use, and an aging population are exacerbating the prevalence of these diseases worldwide. This surge in respiratory health issues underscores the urgent necessity for reliable and effective testing solutions, prompting healthcare providers and patients alike to seek out advanced diagnostic tools. As the demand for precise testing continues to rise, the respiratory disease testing market is expected to experience significant growth in response to these pressing public health challenges.

Restraints in the Global Respiratory Disease Testing Market

The Global Respiratory Disease Testing market faces significant restraints due to rigorous regulatory approval processes. The complexity involved in navigating these regulations can create substantial hurdles for market participants. Securing the necessary approvals for new testing technologies often requires extensive time and financial resources, resulting in prolonged delays for product launches. This situation not only stifles innovation but also restricts the ability of companies to introduce cutting-edge solutions to the market. Consequently, the challenging regulatory landscape may inhibit the overall growth and advancement of the respiratory disease testing sector, limiting potential improvements in patient care and disease management.

Market Trends of the Global Respiratory Disease Testing Market

The Global Respiratory Disease Testing market is witnessing a notable trend towards increased emphasis on point-of-care testing (POCT), which facilitates swift diagnosis and immediate treatment decisions directly at the patient's location. This surge in demand is largely fueled by the need for rapid and precise results, particularly within critical care environments and resource-constrained areas, where traditional laboratory testing may be less feasible. As healthcare providers prioritize quick turnaround times to enhance patient outcomes, the adoption of innovative point-of-care testing devices and platforms is expected to rise significantly, marking a transformative shift in respiratory disease management and testing approaches globally.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Respiratory Disease Testing Market Size by Test Type & CAGR (2024-2031)

• Market Overview
• Mechanical Tests
  • Spirometry
  • Peak-Flow Test
  • Pulmonary Function Test
  • Blood Gas Test
  • Others
• Imaging Tests
  • X-Ray
  • Ct-Scan
  • Ultrasonography
  • Mri
• In-Vitro Diagnostic Tests
  • Point-Of-Care Test
  • Molecular Diagnostic Test

Global Respiratory Disease Testing Market Size by Application & CAGR (2024-2031)

• Market Overview
• Chronic Obstructive Pulmonary Disease
• Lung Cancer
• Asthma
• Tuberculosis
• Other

Global Respiratory Disease Testing Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Hospital
• Physicians Clinic
• Clinical Laboratories

Global Respiratory Disease Testing Market Size & CAGR (2024-2031)

• North America (Test Type, Application, End-Use)
  • USA
  • Canada
• Europe (Test Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Beckton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MG Diagnostic Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ThermoFisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seimens Healthineers AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SDI Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Niterra Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuantuMDx Group Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COSMED srl
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bird Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• visby medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation